SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-129990
Filing Date
2024-12-19
Accepted
2024-12-19 08:00:15
Documents
6
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2431522d1_6k.htm 6-K 16872
2 EXHIBIT 10.1 tm2431522d1_ex10-1.htm EX-10.1 130696
3 EXHIBIT 10.2 tm2431522d1_ex10-2.htm EX-10.2 206925
4 EXHIBIT 10.3 tm2431522d1_ex10-3.htm EX-10.3 100069
5 EXHIBIT 99.1 tm2431522d1_ex99-1.htm EX-99.1 13901
6 GRAPHIC tm2431522d1_ex99-1img001.jpg GRAPHIC 11334
  Complete submission text file 0001104659-24-129990.txt   485339
Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Filer) CIK: 0001985062 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41937 | Film No.: 241561005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)